Review



bmp 2  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress bmp 2
    Flowchart of <t>PaMZ/BMP-2</t> microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release
    Bmp 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bmp 2/product/MedChemExpress
    Average 94 stars, based on 20 article reviews
    bmp 2 - by Bioz Stars, 2026-03
    94/100 stars

    Images

    1) Product Images from "Preparation and in vitro sustained release performance of thermosensitive gel microsphere composite loaded with Anti-Tuberculosis drug PaMZ/BMP-2"

    Article Title: Preparation and in vitro sustained release performance of thermosensitive gel microsphere composite loaded with Anti-Tuberculosis drug PaMZ/BMP-2

    Journal: Journal of Orthopaedic Surgery and Research

    doi: 10.1186/s13018-025-06595-1

    Flowchart of PaMZ/BMP-2 microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release
    Figure Legend Snippet: Flowchart of PaMZ/BMP-2 microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release

    Techniques Used: Construct

    Morphological characterization diagram of PaMZ/BMP-2 microspheres. A Shows the macroscopic appearance of the microspheres observed with the naked eye. B Presents the morphology of the microspheres captured by a computer terminal during the preparation process. C Displays a 400 × magnified image under an optical microscope. D Shows the surface morphology of drug-loaded microspheres after drying and gold sputtering, as observed by field emission scanning electron microscopy
    Figure Legend Snippet: Morphological characterization diagram of PaMZ/BMP-2 microspheres. A Shows the macroscopic appearance of the microspheres observed with the naked eye. B Presents the morphology of the microspheres captured by a computer terminal during the preparation process. C Displays a 400 × magnified image under an optical microscope. D Shows the surface morphology of drug-loaded microspheres after drying and gold sputtering, as observed by field emission scanning electron microscopy

    Techniques Used: Microscopy, Electron Microscopy

    Particle size distribution map of PaMZ/BMP-2 microspheres
    Figure Legend Snippet: Particle size distribution map of PaMZ/BMP-2 microspheres

    Techniques Used:

    X-ray diffraction intensity—diffraction Angle curve of PaMZ/BMP-2 microspheres
    Figure Legend Snippet: X-ray diffraction intensity—diffraction Angle curve of PaMZ/BMP-2 microspheres

    Techniques Used:



    Similar Products

    94
    Multi Sciences (Lianke) Biotech Co Ltd human bmp 2 elisa kit
    The amount <t>of</t> <t>BMP-2</t> in DBM significantly increased in the order of OD > MD > ID using either extracted method, and was more than cortical particles.
    Human Bmp 2 Elisa Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bmp 2 elisa kit/product/Multi Sciences (Lianke) Biotech Co Ltd
    Average 94 stars, based on 1 article reviews
    human bmp 2 elisa kit - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress bmp 2
    Flowchart of <t>PaMZ/BMP-2</t> microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release
    Bmp 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bmp 2/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    bmp 2 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    95
    Croda International Plc bmp 14 0 2
    Flowchart of <t>PaMZ/BMP-2</t> microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release
    Bmp 14 0 2, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bmp 14 0 2/product/Croda International Plc
    Average 95 stars, based on 1 article reviews
    bmp 14 0 2 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    94
    Bioss anti bone morphogenetic protein bmp 2
    Flowchart of <t>PaMZ/BMP-2</t> microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release
    Anti Bone Morphogenetic Protein Bmp 2, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti bone morphogenetic protein bmp 2/product/Bioss
    Average 94 stars, based on 1 article reviews
    anti bone morphogenetic protein bmp 2 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Bioss anti bmp 2
    Flowchart of <t>PaMZ/BMP-2</t> microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release
    Anti Bmp 2, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti bmp 2/product/Bioss
    Average 94 stars, based on 1 article reviews
    anti bmp 2 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    Bioss biotinylated bmp 2
    Flowchart of <t>PaMZ/BMP-2</t> microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release
    Biotinylated Bmp 2, supplied by Bioss, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotinylated bmp 2/product/Bioss
    Average 96 stars, based on 1 article reviews
    biotinylated bmp 2 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Croda International Plc 1 2 dimyristoyl sn glycero 3phosphocholine dmpc
    Flowchart of <t>PaMZ/BMP-2</t> microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release
    1 2 Dimyristoyl Sn Glycero 3phosphocholine Dmpc, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/1 2 dimyristoyl sn glycero 3phosphocholine dmpc/product/Croda International Plc
    Average 96 stars, based on 1 article reviews
    1 2 dimyristoyl sn glycero 3phosphocholine dmpc - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    Image Search Results


    The amount of BMP-2 in DBM significantly increased in the order of OD > MD > ID using either extracted method, and was more than cortical particles.

    Journal: Scientific Reports

    Article Title: Various distribution of BMPs in different periosteal layers contributing to inconsistent osteoinductivity of DBM-based products

    doi: 10.1038/s41598-026-35269-z

    Figure Lengend Snippet: The amount of BMP-2 in DBM significantly increased in the order of OD > MD > ID using either extracted method, and was more than cortical particles.

    Article Snippet: Sandwich enzyme-linked immunosorbent assay (ELISA) was used to assess the amounts of BMP with Commercially available quantikine kits purchased from MULTI SCIENCES (LIANKE) BIOTECH, CO, LTD (human BMP-2 ELISA Kit, sensitivity, 1.73 pg/ml; BMP-7 ELISA Kit, sensitivity, 2.06 pg/ml).

    Techniques:

    The trend of BMP-7 distributed in DBM and cortical particles was similar with BMP-2.

    Journal: Scientific Reports

    Article Title: Various distribution of BMPs in different periosteal layers contributing to inconsistent osteoinductivity of DBM-based products

    doi: 10.1038/s41598-026-35269-z

    Figure Lengend Snippet: The trend of BMP-7 distributed in DBM and cortical particles was similar with BMP-2.

    Article Snippet: Sandwich enzyme-linked immunosorbent assay (ELISA) was used to assess the amounts of BMP with Commercially available quantikine kits purchased from MULTI SCIENCES (LIANKE) BIOTECH, CO, LTD (human BMP-2 ELISA Kit, sensitivity, 1.73 pg/ml; BMP-7 ELISA Kit, sensitivity, 2.06 pg/ml).

    Techniques:

    Through the linear regression analysis, the content of BMP-7 varied linearly with the content of BMP-2 (GuHCl vs. collagenase, R2 = 0.945 vs. R2 = 0.818, respectively).

    Journal: Scientific Reports

    Article Title: Various distribution of BMPs in different periosteal layers contributing to inconsistent osteoinductivity of DBM-based products

    doi: 10.1038/s41598-026-35269-z

    Figure Lengend Snippet: Through the linear regression analysis, the content of BMP-7 varied linearly with the content of BMP-2 (GuHCl vs. collagenase, R2 = 0.945 vs. R2 = 0.818, respectively).

    Article Snippet: Sandwich enzyme-linked immunosorbent assay (ELISA) was used to assess the amounts of BMP with Commercially available quantikine kits purchased from MULTI SCIENCES (LIANKE) BIOTECH, CO, LTD (human BMP-2 ELISA Kit, sensitivity, 1.73 pg/ml; BMP-7 ELISA Kit, sensitivity, 2.06 pg/ml).

    Techniques:

    Flowchart of PaMZ/BMP-2 microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release

    Journal: Journal of Orthopaedic Surgery and Research

    Article Title: Preparation and in vitro sustained release performance of thermosensitive gel microsphere composite loaded with Anti-Tuberculosis drug PaMZ/BMP-2

    doi: 10.1186/s13018-025-06595-1

    Figure Lengend Snippet: Flowchart of PaMZ/BMP-2 microsphere preparation process. The outer phase was prepared by dissolving 0.4 g of polyvinyl alcohol in 20 mL of ultrapure water with stirring at 70 °C until completely dissolved, then slowly cooled to obtain a 2% PVA solution. The inner phase was formed by mixing the inner aqueous phase—comprising 4 mg Moxifloxacin, 15 mg Pyrazinamide, and 1 μg BMP-2 dissolved in 1 mL ultrapure water via 5-min ultrasonication—with the oil phase, which contained 1 mg Pretomanid and 46.67 mg PLGA dissolved in 2.5 mL dichloromethane by 3-min ultrasonication. The two phases were combined by vortex mixing followed by 5 min ultrasonication to form the inner phase liquid. Finally, the PaMZ/BMP-2 thermosensitive gel microsphere composite was constructed using microfluidic technology by combining the inner and outer phases, ensuring high drug loading and controlled release

    Article Snippet: Internal aqueous phase (M/Z/BMP-2 solution) 10 μg of BMP-2 (HY-P7006, MedChemExpress) was dissolved in 10 μL of acetic acid (HAc) as a stock solution.

    Techniques: Construct

    Morphological characterization diagram of PaMZ/BMP-2 microspheres. A Shows the macroscopic appearance of the microspheres observed with the naked eye. B Presents the morphology of the microspheres captured by a computer terminal during the preparation process. C Displays a 400 × magnified image under an optical microscope. D Shows the surface morphology of drug-loaded microspheres after drying and gold sputtering, as observed by field emission scanning electron microscopy

    Journal: Journal of Orthopaedic Surgery and Research

    Article Title: Preparation and in vitro sustained release performance of thermosensitive gel microsphere composite loaded with Anti-Tuberculosis drug PaMZ/BMP-2

    doi: 10.1186/s13018-025-06595-1

    Figure Lengend Snippet: Morphological characterization diagram of PaMZ/BMP-2 microspheres. A Shows the macroscopic appearance of the microspheres observed with the naked eye. B Presents the morphology of the microspheres captured by a computer terminal during the preparation process. C Displays a 400 × magnified image under an optical microscope. D Shows the surface morphology of drug-loaded microspheres after drying and gold sputtering, as observed by field emission scanning electron microscopy

    Article Snippet: Internal aqueous phase (M/Z/BMP-2 solution) 10 μg of BMP-2 (HY-P7006, MedChemExpress) was dissolved in 10 μL of acetic acid (HAc) as a stock solution.

    Techniques: Microscopy, Electron Microscopy

    Particle size distribution map of PaMZ/BMP-2 microspheres

    Journal: Journal of Orthopaedic Surgery and Research

    Article Title: Preparation and in vitro sustained release performance of thermosensitive gel microsphere composite loaded with Anti-Tuberculosis drug PaMZ/BMP-2

    doi: 10.1186/s13018-025-06595-1

    Figure Lengend Snippet: Particle size distribution map of PaMZ/BMP-2 microspheres

    Article Snippet: Internal aqueous phase (M/Z/BMP-2 solution) 10 μg of BMP-2 (HY-P7006, MedChemExpress) was dissolved in 10 μL of acetic acid (HAc) as a stock solution.

    Techniques:

    X-ray diffraction intensity—diffraction Angle curve of PaMZ/BMP-2 microspheres

    Journal: Journal of Orthopaedic Surgery and Research

    Article Title: Preparation and in vitro sustained release performance of thermosensitive gel microsphere composite loaded with Anti-Tuberculosis drug PaMZ/BMP-2

    doi: 10.1186/s13018-025-06595-1

    Figure Lengend Snippet: X-ray diffraction intensity—diffraction Angle curve of PaMZ/BMP-2 microspheres

    Article Snippet: Internal aqueous phase (M/Z/BMP-2 solution) 10 μg of BMP-2 (HY-P7006, MedChemExpress) was dissolved in 10 μL of acetic acid (HAc) as a stock solution.

    Techniques: